All Clinical Trials
Mater conducts clinical trials in a range of therapeutic areas including Cance, Nerouology, Medicine, Orthopaedics Surgery and Acute Care, and Mothers' and Babies Health. Clinical trials are an essential component of helathcare. They provide the evidence to evaluate the safety and efficacy of new treantments and diagnositics, and provide alternative treatment options for patients with unmet needs.
CROSSING - A new treatment for Eosinophilic Esophagitis
A study of the safety and effectiveness of tezepelumab in adolescent and adult participants with Eosinophilic Esophagitis
DEPART - Seeking cancer patients with nerve pain
Duloxetine versus pregabalin to treat opioid-resistant nerve pain in cancer patients.
ELAINE-3
An Open Label, Randomized, Multicenter Study Comparing the Efficacy and Safety of the Combination of Lasofoxifene and Abemaciclib to the Combination of Fulvestrant and Abemaciclib for the Treatment of Pre- and Postmenopausal Women and Men with Locally Advanced or Metastatic ER+/HER2− Breast Cancer with an ESR1 Mutation.
ElevAAte - New Treatment for Adults with Alpha-1 Antitrypsin Deficiency (AATD) Emphysems
Study to compare INBRX-101 to plasma derived A1PI therapy in adults with AATD Emphysema
EMERALD2 - A new treatment for Ulcerative Colitis
A phase 2b study to evaluate MORF-057 in adults with moderately to severely active ulcerative colitis (UC).
ENGAGE
A study investigating the effectiveness & safety of Dupilumab in the treatment of eosinophilic gastritis with or without eosinophilic duodenitis.
FAME 1 Eye research study - A new treatment for retinopathy in type 1 diabetes
Testing the safety and effectiveness of Fenofibrate in reducing diabetic retinopathy in adults with Type 1 diabetes
FOCUSau: Improving the wellbeing of people with advanced cancer and their family carers
Improving the wellbeing of people with advanced cancer and their family carers: An effectiveness implementation trial of an Australian dyadic digital health intervention (FOCUSau).
frontMIND - A new treatment for newly diagnosed lymphoma
A clinical trial of investigational drug tafasitamab plus lenalidomide in addition to standard therapy for treatment of newly diagnosed high and intermediate risk diffuse large B-cell lymphoma (DLBCL)
FUZION - A potential treatment for Fistulizing, Perianal Crohn’s Disease
FUZION: Efficacy and safety of guselkumab in participants with fistulizing, perianal Crohn’s Disease